Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

1.04
+0.04004.00%
Pre-market: 1.060.0200+1.92%04:58 EDT
Volume:5.25M
Turnover:5.37M
Market Cap:216.99M
PE:-1.49
High:1.06
Open:1.06
Low:0.9613
Close:1.00
Loading ...

Sangamo Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
07 Mar

Press Release: Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference

Dow Jones
·
07 Mar

Sangamo Therapeutics (NASDAQ:SGMO shareholders incur further losses as stock declines 15% this week, taking five-year losses to 89%

Simply Wall St.
·
28 Feb

Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes

Benzinga
·
22 Feb

Sangamo Therapeutics Inc - Isaralgagene Civaparvovec Generally Well-Tolerated With Most Adverse Events Grade 1-2

THOMSON REUTERS
·
06 Feb

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

THOMSON REUTERS
·
06 Feb

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

Business Wire
·
06 Feb

Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Jan

Sangamo Therapeutics Is Maintained at Buy by Truist Securities

Dow Jones
·
24 Jan

Truist Financial Keeps Their Buy Rating on Sangamo Biosciences (SGMO)

TIPRANKS
·
23 Jan

Sangamo Therapeutics Inc. (SGMO): This Small-Cap Stock Is Poised To Outperform in 2025

Insider Monkey
·
08 Jan

Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

Zacks
·
03 Jan

Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
02 Jan

Company News for Jan 2, 2025

Zacks
·
02 Jan

Post-Bell | Wall Street Ends Lower; Nvidia and Palantir Drop 2%; Tesla Declines 3%; MicroStrategy Sinks 4%

Tiger Newspress
·
01 Jan

US Equities Markets End Lower Tuesday In Last Trading Session of 2024

MT Newswires Live
·
01 Jan